TICAFILL-90
| Brand | TICAFILL-90 |
|---|---|
| Composition | Ticagrelor 90mg TABLET |
| Packing | 10x14 |
| Pack Type | Tab |
For pharmaceutical trade buyers, not patient or consumer sales. This record reproduces company product information, not medical advice. Current product availability and terms are confirmed by Intra Life.
Enquire about TICAFILL-90Indication
Reduction of the risk of cardiovascular death, myocardial infarction and stroke in patients with acute coronary syndrome, under specialist-directed antiplatelet therapy.
Mechanism of action
Ticagrelor reversibly inhibits the platelet P2Y12 ADP receptor, reducing platelet activation and aggregation.
For pharmaceutical trade information, not a patient-specific prescription. Use the current approved product insert and the prescribing clinician's directions.
TICAFILL-90 for B2B enquiries
Distributors, stockists, medical stores, hospitals and PCD franchise buyers can share their city, quantity and product requirements. Ask the team for current supply, packing and trade terms.
Ask for trade details on WhatsAppKeep exploring
Browse related brand searches · All published products · Browse divisions